The test for exocrine pancreatic function using Nbenzoyl-L-tyrosyl-p-aminobenzoic acid (BTPABA test) was assessed in 7 patients with giardiasis and 7 healthy controls. Cumulative percent p-aminobenzoic acid (PABA) recovery in 6 hr was significantly lower in patients with giardiasis, compared with the control group. When an equivalent dose of free PABA was given, there were no differences in PABA recovery between the groups. In patients with giardiasis, the post-treatment values of BTPABA test were significantly higher than the pretreatment values and no differences were found in PABA recovery between patients with giardiasis after eradication and healthy controls. These findings indicate that Giardia lamblia interferes with the action of pancreatic chymotrypsin. It is noteworthy that giardiasis could cause an abnormal BTPABA test.
Introduction
Although giardiasis as a cause of diarrhoea, malabsorption and biliary tract dysfunction (Petersen, 1972; Ericraizman, 1976;  Goldstein, Thornton and Szydrowski, 1978; Jahadi, 1978) has been increasingly recognized in the world, little attention has been paid to the assessment of exocrine pancreatic function in patients with giardiasis. The present study reports that Giardia lamblia interferes with the action of pancreatic chymotrypsin.
Patients
Fourteen subjects were studied, 7 controls and 7 patients.
Controls
There were 5 men and 2 women healthy volunteers, aged 21-78 years (mean 49 1). In none was there clinical or laboratory evidence of gastrointestinal, hepatobiliary, pancreatic, or renal disease. There was no history of alcoholism.
Patients
Seven consecutive patients with giardiasis, 6 men and one woman, admitted to our clinic during the period from October 1979 to. December 1981, were studied. The ages ranged from 27 to 59 years (mean 39 7). The diagnosis of giardiasis was confirmed by both stool examination and microscopic examination of the duodenal aspirate. Of these, 5 patients had symptoms such as upper abdominal pain, low grade fever, general malaise, and soft stool. The remaining two patients were asymptomatic; one admitted for acromegaly, the other for a check-up. All patients had normal renal and liver function values and normal findings on oral cholecystography, barium meal and small intestinal X-rays. In no patient was there a history of alcoholism.
Methods
The following were performed to all subjects: The results of the free PABA test are shown in Fig.  2 . Values in the control group were 86.9 ± 5.9% compared with 84 3 ± 5 3% in giardiasis, a difference that was not statistically significant.
In patients with giardiasis, the results of the BTPABA test were compared before and after eradication (Fig. 3) . The recovery rate of PABA was significantly higher after treatment (P<0 001). With therapy, the symptoms disappeared in 5 patients who had symptoms before treatment. There were no significant differences between patients with giardiasis after eradication and the controls.
Discussion
Giardia lamblia is an inhabitant of the upper gastrointestinal tract close to the opening of the pancreatic duct. Thus, it was proposed that the protozoon caused pancreatic insufficiency by invading the pancreatic duct (DeMuro, 1939) . However, little information is available in the literature regard- ing the status of pancreatic enzymes in giardiasis. Gupta and Mehta (1973) and Chawla et al. (1975) reported that tryptic activity in the duodenal aspirate was significantly lower in patients with giardiasis in comparison with the controls and a significant improvement occurred after eradication. BTPABA, a synthetic peptide used for an exocrine pancreatic function test (BTPABA test), is specifically cleaved by pancreatic chymotrypsin and the released PABA is rapidly absorbed from the small intestine, conjugated in the liver and excreted in the urine (Imondi, Stradley and Wolgemuth, 1972; deBenneville et al., 1972) . Accordingly, the amount of PABA recovered in the urine after oral administration of BTPABA may be used as an index of exocrine pancreatic function. Previous studies showed that the BTPABA test enabled detection of pancreatic disease and that the results correlated well with tests using duodenal intubation (Arvanitakis and Greenberger, 1976; Gyr et al., 1976; Bornschein, Goldmann and Otte, 1976; Imamura et al., 1978; Kimura, Wakasugi and Ibayashi, 1981) . However, this test could produce misleadingly abnormal results in patients with malabsorption, liver disease or renal disease, because recovery of PABA in the urine depends not only on chymotrypsin hydrolysis but also on the absorption, conjugation and excretion of PABA. Such misleading results can be excluded by performing a test (free PABA test), replacing oral BTPABA with PABA, to correct for abnormal PABA absorption, metabolism and excretion (Mitchell et al., 1979 (Mitchell et al., , 1981 Kimura et al., 1979) .
In our study, the recovery rate of PABA in the BTPABA test was significantly lower in patients with giardiasis than in the controls, though in the free PABA test no differences were found between the groups. Moreover, in patients with giardiasis, the post-treatment values in the PTPABA test were significantly higher than the pretreatment values. These findings indicate that Giardia lamblia interferes with the action of pancreatic chymotrypsin.
Although its exact cause is unclear, there seem to be several possible mechanisms-direct pancreatic parenchymal damage, mechanical blockage of pancreatic duct, interference with the activating system of pancreatic enzymes in the duodenum and production of inhibitor of pancreatic enzymes, and bacterial overgrowth interfering with chymotrypsin activation.
